Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
swelling	O
of	O
RLE	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
___	O
only	O
with	O
hx	O
of	O
venous	O
stasis	O
ulcers,	O
recurrent	O
cellulitis	O
presenting	O
with	O
RLE	O
swelling,	O
warmth,	O
and	O
pain	O
x1	O
week.	O
Patient	O
reports	O
that	O
he	O
has	O
a	O
circumferential	O
scar	O
as	O
a	O
teenager	O
and	O
annually	O
RLE	O
swelling	O
and	O
cellulitis	O
requiring	O
hospitalization	O
for	O
IV	O
abx.	O
Denies	O
history	O
of	O
blood	O
clot.	O
Pt	O
travels	O
back	O
and	O
forth	O
between	O
___	O
and	O
___.	O
He	O
flew	O
to	O
the	O
___	O
for	O
treatment	O
on	O
the	O
day	O
prior	O
to	O
presentation.	O
On	O
review	O
of	O
OMR,	O
he	O
has	O
had	O
4	O
similar	O
presentations,	O
most	O
recently	O
in	O
___,	O
for	O
___	O
cellulitis	O
requiring	O
IV	O
abx.	O
Culture	O
data	O
has	O
never	O
revealed	O
an	O
organism.	O
In	O
the	O
___	O
ED:	O
98.3,	O
95,	O
180/133->154/61,	O
20,	O
98%	O
RA	O
Labs	O
notable	O
for	O
WBC	O
11.7,	O
Hb	O
10.7	O
LA	O
1.5	O
___	O
negative	O
for	O
DVT	O
UA	O
negative	O
Received	O
1L	O
NS	O
Vancomycin	O
1	O
gram	O
x1	O
Morphine	O
sulfate	O
2	O
mg	O
IV	O
x1	O
Past	O
Medical	O
History:	O
HTN	O
GERD	O
Chronic	O
venous	O
stasis	O
with	O
recurrent	O
cellulitis	O
Diverticulosis	O
Low	O
back	O
pain	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
history	O
of	O
immunodeficiency.	O
Physical	O
Exam:	O
VS:	O
97.7,	O
162/71,	O
80,	O
18,	O
100%	O
RA	O
HEENT:	O
clear	O
oropharynx,	O
MMM	O
Neck:	O
Supple,	O
no	O
cervical	O
or	O
supraclavicular	O
adenopathy	O
CV:	O
RRR,	O
no	O
m/r/g	O
Lungs:	O
CTAB,	O
no	O
wheeze	O
or	O
rales	O
Abd:	O
soft,	O
NT,	O
ND,	O
no	O
rebound	O
or	O
guarding,	O
+bowel	O
sounds	O
GU:	O
No	O
foley	O
Ext:	O
WWP,	O
RLE	O
with	O
erythema	O
and	O
desquamation	O
to	O
level	O
of	O
knee,	O
without	O
drainage	O
or	O
palpable	O
discrete	O
collections,	O
2+	O
pitting	O
edema	O
to	O
knee	O
Neuro:	O
Unable	O
to	O
assess	O
___	O
language	O
barrier,	O
grossly	O
intact	O
DISCHARGE	O
EXAM:	O
GEN:	O
No	O
acute	O
distress,	O
comfortable	O
appearing	O
HEENT:	O
NCAT,	O
anicteric	O
sclera	O
CV:	O
Normal	O
S1,	O
S2,	O
no	O
murmurs	O
RESP:	O
Good	O
air	O
entry,	O
no	O
rales	O
or	O
wheezes	O
ABD:	O
Normal	O
bowel	O
sounds,	O
soft,	O
non-tender,	O
non-distended,	O
no	O
rebound/guarding;	O
EXTR:	O
RLE	O
1+	O
pitting	O
edema	O
(significantly	O
diminished	O
from	O
admission);	O
sloughing	O
of	O
skin	O
on	O
anterior	O
shins	O
bilaterally;	O
chronic	O
appearing	O
blisters;	O
no	O
significant	O
erythema,	O
warmth	O
or	O
drainage	O
of	O
the	O
lower	O
extremities.	O
dry	O
ulcer	O
on	O
dorsal	O
surface	O
of	O
right	O
___	O
toe;	O
no	O
clearly	O
demarcated	O
erythema	O
due	O
to	O
dark	O
skin	O
color;	O
tender,	O
firm	O
suprapatellar	O
bursa,	O
full	O
passive	O
range	O
of	O
motion,	O
no	O
effusions	O
NEURO:	O
Face	O
symmetric,	O
speech	O
fluent,	O
non-focal	O
PSYCH:	O
Calm,	O
cooperative	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
___	O
11:10PM	O
GLUCOSE-102*	O
UREA	O
N-14	O
CREAT-1.0	O
SODIUM-135	O
POTASSIUM-4.5	O
CHLORIDE-102	O
TOTAL	O
CO2-22	O
ANION	O
GAP-16	O
___	O
11:10PM	O
estGFR-Using	O
this	O
___	O
11:10PM	O
WBC-11.7*#	O
RBC-3.29*	O
HGB-10.7*	O
HCT-32.9*	O
MCV-100*	O
MCH-32.5*	O
MCHC-32.5	O
RDW-12.3	O
RDWSD-45.3	O
___	O
11:10PM	O
NEUTS-70	O
BANDS-2	O
___	O
MONOS-7	O
EOS-0	O
BASOS-1	O
___	O
MYELOS-0	O
AbsNeut-8.42*	O
AbsLymp-2.34	O
AbsMono-0.82*	O
AbsEos-0.00*	O
AbsBaso-0.12*	O
___	O
11:10PM	O
HYPOCHROM-NORMAL	O
ANISOCYT-NORMAL	O
POIKILOCY-NORMAL	O
MACROCYT-1+	O
MICROCYT-NORMAL	O
POLYCHROM-NORMAL	O
TEARDROP-1+	O
___	O
11:10PM	O
PLT	O
SMR-NORMAL	O
PLT	O
COUNT-297	O
___	O
09:59PM	O
COMMENTS-GREEN	O
TOP	O
___	O
09:59PM	O
LACTATE-1.5	O
___	O
09:30PM	O
URINE	O
HOURS-RANDOM	O
___	O
09:30PM	O
URINE	O
HOURS-RANDOM	O
___	O
09:30PM	O
URINE	O
UHOLD-HOLD	O
___	O
09:30PM	O
URINE	O
GR	O
HOLD-HOLD	O
___	O
09:30PM	O
URINE	O
COLOR-Yellow	O
APPEAR-Clear	O
SP	O
___	O
___	O
09:30PM	O
URINE	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-TR	O
GLUCOSE-NEG	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-5.5	O
LEUK-MOD	O
___	O
09:30PM	O
URINE	O
RBC-7*	O
WBC-13*	O
BACTERIA-NONE	O
YEAST-NONE	O
EPI-<1	O
___	O
09:30PM	O
URINE	O
MUCOUS-RARE	O
UNILAT	O
LOWER	O
EXT	O
VEINS	O
RIGHT:	O
No	O
evidence	O
of	O
deep	O
venous	O
thrombosis	O
in	O
the	O
right	O
lower	O
extremity	O
veins.	O
ULTRASOUND	O
KNEE:	O
Thickened	O
edematous	O
soft	O
tissue	O
over	O
the	O
suprapatellar	O
right	O
knee	O
without	O
evidence	O
of	O
fluid	O
collection	O
or	O
joint	O
effusion.	O
FOOT	O
X-RAY:	O
In	O
comparison	O
with	O
the	O
study	O
of	O
___,	O
there	O
again	O
is	O
severe	O
degenerative	O
change	O
with	O
narrowing	O
and	O
spurring	O
involving	O
the	O
first	O
metatarsophalangeal	O
joint.	O
There	O
is	O
been	O
a	O
dramatic	O
increase	O
in	O
soft	O
tissue	O
swelling	O
dorsally	O
at	O
the	O
level	O
of	O
the	O
metatarsals,	O
consistent	O
with	O
the	O
clinical	O
history	O
of	O
recurrent	O
cellulitis.	O
However,	O
there	O
is	O
no	O
definite	O
evidence	O
of	O
bone	O
destruction,	O
or	O
gas	O
or	O
opaque	O
foreign	O
body	O
in	O
soft	O
tissues.	O
Nevertheless,	O
if	O
there	O
is	O
strong	O
clinical	O
suspicion	O
for	O
osteomyelitis,	O
MRI	O
could	O
be	O
obtained.	O
Postsurgical	O
changes	O
are	O
again	O
seen	O
in	O
the	O
calcaneus	O
posteriorly.	O
DISCHARGE	O
LABS:	O
___	O
07:00AM	O
BLOOD	O
WBC-7.7	O
RBC-3.40*	O
Hgb-10.9*	O
Hct-34.2*	O
MCV-101*	O
MCH-32.1*	O
MCHC-31.9*	O
RDW-11.9	O
RDWSD-44.0	O
Plt	O
___	O
___	O
07:00AM	O
BLOOD	O
Glucose-79	O
UreaN-13	O
Creat-1.0	O
Na-136	O
K-4.6	O
Cl-101	O
HCO3-28	O
AnGap-12	O
___	O
07:00AM	O
BLOOD	O
Calcium-9.0	O
Phos-4.0	O
Mg-2.1	O
___	O
07:00AM	O
BLOOD	O
CRP-170.1*	O
Brief	O
Hospital	O
Course:	O
___	O
___	O
only	O
with	O
hx	O
of	O
venous	O
stasis	O
ulcers,	O
recurrent	O
cellulitis	O
presenting	O
with	O
recurrent	O
RLE	O
cellulitis.	O
#	O
RLE	O
cellulitis	O
/	O
question	O
suprapatellar	O
bursitis:	O
No	O
prior	O
micro	O
data	O
to	O
guide	O
treatment.	O
Has	O
previously	O
responded	O
well	O
to	O
gram	O
positive	O
coverage,	O
and	O
most	O
recently	O
was	O
discharged	O
on	O
cephalexin.	O
There	O
was	O
concern	O
during	O
his	O
last	O
hospitalization	O
about	O
small	O
foreign	O
body	O
seen	O
on	O
foot	O
xray,	O
although	O
this	O
was	O
involving	O
his	O
LLE.	O
Lower	O
extremity	O
ultrasound	O
was	O
negative	O
for	O
DVT.	O
There	O
was	O
an	O
area	O
of	O
induration	O
above	O
the	O
knee,	O
but	O
ultrasound	O
showed	O
no	O
significant	O
fluid	O
collection.	O
Appears	O
to	O
have	O
changes	O
consistent	O
with	O
chronic	O
venous	O
stasis	O
and	O
a	O
small	O
dry	O
ulcer	O
on	O
his	O
___	O
toe	O
on	O
the	O
right,	O
which	O
likely	O
predisposed	O
him	O
to	O
infection.	O
He	O
was	O
evaluated	O
by	O
podiatry	O
who	O
recommended	O
betadine	O
dressing	O
changes	O
and	O
outpatient	O
follow-up.	O
Patient	O
improved	O
significantly	O
with	O
IV	O
vancomycin,	O
and	O
was	O
transitioned	O
to	O
clindamycin	O
to	O
complete	O
a	O
7	O
day	O
course.	O
Other	O
than	O
mild	O
leukocytosis,	O
he	O
demonstrated	O
no	O
signs	O
of	O
systemic	O
infection.	O
#	O
Hypertension:	O
Discharge	O
meds	O
include	O
hctz	O
25	O
mg	O
daily,	O
lisinopril	O
40	O
mg	O
daily,	O
and	O
metoprolol	O
tartrate	O
25	O
mg	O
BID.	O
Hypertensive	O
on	O
admission	O
to	O
ED.	O
Continued	O
all	O
home	O
medications,	O
but	O
of	O
note	O
neither	O
myself	O
nor	O
the	O
PACT	O
team	O
could	O
obtain	O
an	O
accurate	O
list	O
of	O
current	O
medications	O
-	O
patient	O
does	O
not	O
know	O
his	O
medications	O
and	O
has	O
not	O
filled	O
any	O
scripts	O
in	O
the	O
US	O
for	O
several	O
months.	O
#	O
GERD:	O
Cont	O
home	O
PPI	O
#	O
BPH:	O
Cont	O
home	O
tamsulosin	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
may	O
be	O
inaccurate	O
and	O
requires	O
futher	O
investigation.	O
1.	O
Hydrochlorothiazide	O
25	O
mg	O
PO	O
DAILY	O
2.	O
Lisinopril	O
40	O
mg	O
PO	O
DAILY	O
3.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
BID	O
4.	O
Omeprazole	O
40	O
mg	O
PO	O
DAILY:PRN	O
heartburn	O
5.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
QHS	O
Discharge	O
Medications:	O
1.	O
Hydrochlorothiazide	O
25	O
mg	O
PO	O
DAILY	O
RX	O
*hydrochlorothiazide	O
25	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
2.	O
Lisinopril	O
40	O
mg	O
PO	O
DAILY	O
RX	O
*lisinopril	O
40	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
DAILY	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
3.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
BID	O
RX	O
*metoprolol	O
tartrate	O
25	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*60	O
Tablet	O
Refills:*0	O
4.	O
OxycoDONE	O
(Immediate	O
Release)	O
___	O
mg	O
PO	O
Q6H:PRN	O
pain	O
RX	O
*oxycodone	O
5	O
mg	O
___	O
tablet(s)	O
by	O
mouth	O
every	O
six	O
(6)	O
hours	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
5.	O
Omeprazole	O
40	O
mg	O
PO	O
DAILY:PRN	O
heartburn	O
RX	O
*omeprazole	O
40	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Capsule	O
Refills:*0	O
6.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
QHS	O
RX	O
*tamsulosin	O
0.4	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
HS	O
Disp	O
#*30	O
Capsule	O
Refills:*0	O
7.	O
Clindamycin	O
300	O
mg	O
PO	O
Q6H	O
Duration:	O
7	O
Days	O
RX	O
*clindamycin	O
HCl	O
300	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
every	O
six	O
(6)	O
hours	O
Disp	O
#*28	O
Capsule	O
Refills:*0	O
Discharge	O
Disposition:	O
Home	B-Has_carers
With	B-Has_carers
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Cellulitis	O
Venous	O
stasis	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
for	O
cellulitis	O
(an	O
infection	O
of	O
the	O
skin	O
in	O
your	O
leg).	O
You	O
were	O
treated	O
with	O
antibiotics	O
and	O
the	O
infection	O
improved.	O
It	O
is	O
important	O
that	O
you	O
continue	O
to	O
take	O
antibiotics	O
as	O
prescribed,	O
clean,	O
and	O
care	O
for	O
your	O
wounds	O
as	O
instructed.	O
Please	O
follow	O
up	O
with	O
your	O
PCP	O
and	O
podiatrist	O
___	O
Instructions:	O
___	O

